Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20
±³À°ÀÏÀÚ : 2024-07-20
±³À°Àå¼Ò : ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : À¯ÁöÀÎ
¿¬¶ôó : 02-714-9072
À̸ÞÀÏ : diabetes@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í "Àü¹®ÀÇ, ÀüÀÓÀÇ, °³¿øÀÇ: »çÀü 50,000¿ø / ÇöÀå 70,000¿ø
Àü°øÀÇ, ¿¬±¸¿ø, Çлý: »çÀü 30,000¿ø / ÇöÀå 40,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 09:10~09:40 Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases ¼Û¹ÎÈ£(KAIST)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 09:40~10:00 Methods for Reducing Bias in Pharmacoepidemiological Studies Using Secondary Healthcare Data ±è´ëÁß(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:00~10:20 Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases Á¶¿µ¹Î(¼¿ïÀÇ´ë)
Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:20~10:40 Q&A ( )
ÈÞ½Ä 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:40~11:00 Break ( )
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Reflections on My Evolution as a Researcher À̽Âȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:40 Looking Back: The Early Days of My Research Journey ±è±Ô¸®(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:40~12:00 ³ªÀÇ ¿¬±¸ ºÐÅõ±â- Collaboration Wins All ¹®Áؼº(¿µ³²ÀÇ´ë)
Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 12:00~12:10 Q&A ( )
½Ä»ç 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 12:10~13:10 Lunch Break ( )
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:10~13:30 ³»ºÐºñ ¿¬±¸¿¡¼ÀÇ ¿þ¾î·¯ºíµð¹ÙÀ̽ºÀÇ È°¿ë ±è°æÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:30~13:50 Current Status of Fully Closed-Loop System (Automated Insulin Delivery) ¹®¼±ÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:50~14:10 ³»ºÐºñ ºÐ¾ßÀÇ Áø·á ¹× ¿¬±¸¿¡¼ÀÇ chatGPTÀÇ È°¿ë ±è°æ¹Î(¿¬¼¼ÀÇ)
Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:10~14:20 Q&A ( )
ÈÞ½Ä 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:20~14:40 Break ( )
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:40~15:00 ´ë±Ô¸ð µ¥ÀÌÅÍÀÇ À¶ÇÕ ¹× AI¸¦ ÅëÇÑ In Silico LabÀÇ ±¸Ãà°ú Clinical Translation ÃÖÈ«À±(Æ÷Æ®·¡ÀÌ)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:00~15:20 AI¸¦ È°¿ëÇÑ ÀûÀÀÁõ È®Àå ±èÀ̶û(¿ÂÄÚÅ©·Î½º)
±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:20~15:40 Clinical Proteomics and its Data Analysis for Drug Target Discovery and Diagnosis / Monitoring ±è°æ°ï(¾Æ»ê»ý¸í°úÇבּ¸¿ø)
Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:40~15:50 Q&A ( )